India IVF Is Building Technology Into Every Stage of IVF, From the Lab Bench to the Patient’s Home

The fertility network is applying robotics, remote monitoring and needle-free drug delivery to three different problems: precision in the procedure, quality in the laboratory and comfort for the patient.

When people talk about technology in IVF, they usually mean the moment of fertilisation. A couple going through treatment lives through something much longer: weeks of daily injections at home, a procedure they never see, and days in which their embryos grow inside a laboratory they will never enter.

India IVF Fertility, founded in 2014 and now a network of ten centres across Delhi-NCR, Jammu & Kashmir and Madhya Pradesh, has built its technology programme around that full journey. Instead of investing in one headline machine, it has introduced tools at three separate points: Robo-ICSI for the procedure, i-Womb for the laboratory and needle-free medication delivery for the patient.

“Technology in IVF is often treated as a showpiece,” says Dr. Somendra Shukla, Co-founder and CEO of India IVF. “We ask a plainer question. Where does a process depend too heavily on one person’s hands, one person’s memory or one patient’s tolerance for pain? That is where technology should go.”

Robo-ICSI: a steadier hand for the most delicate step

ICSI, in which a single sperm is injected into an egg with a fine glass needle, is among the most delicate tasks in an IVF laboratory. A human egg is about a tenth of a millimetre across, and in the conventional method the needle is guided by hand. The work depends on the skill of the individual embryologist, and natural hand tremor and differences in technique introduce variation.

Robo-ICSI, which India IVF introduced as India’s first, uses AI-assisted, precision-controlled robotic movement to position and move the needle. It removes hand tremor from the injection step, reduces variation between operators and can shorten the time each egg spends outside the incubator. The embryologist stays in charge throughout, selecting the sperm and supervising every step.

“The machine does not replace judgement,” says Dr. Richika Sahay Shukla, Co-founder and Medical Director. “It gives our embryologists a steadier, more consistent way to carry out a step that has always depended on the steadiness of a human hand.”

i-Womb: a laboratory monitored every minute

Embryos spend their first days in an incubator, and they are sensitive to small shifts in temperature, humidity and gas concentration. In many IVF laboratories these readings are still checked and logged by hand at intervals, which leaves gaps and depends on how consistently staff are trained.

i-Womb is India IVF’s answer, a system developed in-house and trademarked by the company. Data loggers continuously track room temperature and humidity; the carbon dioxide, oxygen, humidity and temperature inside incubators; and the temperature and liquid nitrogen level of the cryocans in which eggs, sperm and embryos are stored. A software layer reads this data around the clock, flags any deviation and alerts the responsible team so that it can be corrected immediately.

The value is greatest away from the metros. As the network grows in cities such as Gwalior and Srinagar, i-Womb lets senior embryologists check on a laboratory in another city. “A couple in a smaller city should get a laboratory held to the same standard as one in Delhi,” says Dr. Somendra Shukla. “You cannot do that with a clipboard. You need a system that records everything and tells you the moment something drifts.”

Needle-free delivery: easing the hardest part for patients

For many women, the hardest part of IVF is not the procedure but the injections. Ovarian stimulation typically runs for 10 to 12 days, with one or more hormone injections every day, often self-administered at home. Fear of needles leads some women to put off treatment altogether.

India IVF has introduced needle-free technology that delivers suitable fertility medicines through the skin without a conventional needle. It is offered on the basis of clinical suitability and does not replace standard injections for every medicine or every patient; the treating doctor decides which method is appropriate.

“We have met women who delayed treatment for months because of the injections,” says Dr. Richika Sahay Shukla. “That fear is real, and it deserves a practical answer.”

Three problems, one approach

What links the three is a view of where quality in IVF is actually decided: in the steps that used to rest on individual skill, manual checks or patient endurance. Each tool makes one of those steps more consistent and easier to audit.

That matters for a network run on a hub-and-spoke model, where hub laboratories support consultation centres in surrounding towns. Standardised, monitored processes let the same protocols travel from one city to the next.

India IVF is clear that none of this substitutes for clinical judgement or for time with the doctor. “Technology should make care more precise and more humane at the same time,” says Dr. Somendra Shukla. “If it only does the first, we have missed half the point. What matters to a couple is that they are looked after properly at every stage, including the ones they never see.”

Share on